Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 6 | $832,996 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
19 Mar 2024 16:03 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 18 Mar 2024 | Sale | 9,913 | 56.9 | 564,050 | D |
13 Feb 2024 16:38 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 12 Feb 2024 | Sale | 597 | 67.7669 | 40,457 | D |
31 Jan 2024 16:18 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 29 Jan 2024 | Sale | 367 | 64.1382 | 23,539 | D |
23 Jan 2024 18:01 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 22 Jan 2024 | Sale | 1,384 | 64.996 | 89,954 | D |
17 Jan 2024 16:41 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 16 Jan 2024 | Sale | 1,631 | 66.8086 | 108,965 | D |
24 Oct 2023 16:18 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 23 Oct 2023 | Sale | 131 | 46.0362 | 6,031 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)